Changes to Biohit Oyj’s management

Publishing on September 6, 2022 at 14:00 am local time (EEST)

MSc (Econ and Bus Admin) Jussi Sorvo (b. 1990) has been appointed Chief Financial Officer and as a member of the Management Team of Biohit Oyj starting September 7th, 2022. He will also be responsible for HR and ICT functions. Sorvo will report to CEO Jussi Hahtela. Sorvo has worked at Biohit as a business controller since June 2021. Previously he has worked at PwC as an auditor and in data-analytics utilization and other reporting development projects.

Additional information: 
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com